Factors Associated With Prevalence and Treatment of Primary Biliary Cholangitis in United States Health Systems
暂无分享,去创建一个
K. Lindor | M. Raebel | J. Boscarino | M. Turner | S. Trudeau | J. Vanwormer | R. Romanelli | J. Mor | C. Bowlus | Yueren Zhou | S. Gordon | Carla V. Rodriguez | Jia Li | J. Vincent | Talan Zhang | V. Chiu | Sally F. Shaw | L. Pieper | Mei Lu | Mark A. Schmidt | L. Rupp | Y. Daida | H. Anderson | I. Haller | A. Sahota | Carmen P Wong | Kevin B. Rubenstein | Zahra Daar | Judy L. Donald | Shamyal H Khan | N. Akkerman | D. Kohnhorst | Han-wei Wu | Dana Larkin | Christina Melkonian | Rene Everline | Nishat Islam | Jacquelyn L. Redd | Kathy Bow | Nathan Tesch | Solomon Trimble | Mario de los Santos | Tina Amlin | K. Dunlap | M. Schmidt
[1] F. Carrat,et al. Large‐scale characterization study of patients with antimitochondrial antibodies but nonestablished primary biliary cholangitis , 2017, Hepatology.
[2] I. Mackay,et al. Evolving Trends in Female to Male Incidence and Male Mortality of Primary Biliary Cholangitis , 2016, Scientific Reports.
[3] Hwa Young Choi,et al. Population‐based epidemiology of primary biliary cirrhosis in South Korea , 2016, Alimentary pharmacology & therapeutics.
[4] E. Schiff,et al. Hispanics with primary biliary cirrhosis are more likely to have features of autoimmune hepatitis and reduced response to ursodeoxycholic acid than non-Hispanics. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[5] C. Ponsioen,et al. Rising incidence and prevalence of primary biliary cirrhosis: a large population‐based study , 2014, Liver international : official journal of the International Association for the Study of the Liver.
[6] Roy Pardee,et al. The HMO Research Network Virtual Data Warehouse: A Public Data Model to Support Collaboration , 2014, EGEMS.
[7] R. Gambino,et al. Gender specific medicine in liver diseases: a point of view. , 2014, World journal of gastroenterology.
[8] C. Selmi,et al. The limitations and hidden gems of the epidemiology of primary biliary cirrhosis. , 2013, Journal of autoimmunity.
[9] T. Kumagi,et al. Natural history and management of primary biliary cirrhosis , 2012, Hepatic medicine : evidence and research.
[10] C. Ponsioen,et al. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. , 2012, Journal of hepatology.
[11] M. Zervos,et al. Prediction of Failure in Vancomycin-Treated Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: a Clinically Useful Risk Stratification Tool , 2011, Antimicrobial Agents and Chemotherapy.
[12] H. Quan,et al. Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: A population‐based study , 2009, Hepatology.
[13] Jason Fine,et al. Sample size for positive and negative predictive value in diagnostic research using case-control designs. , 2008, Biostatistics.
[14] J. Lake,et al. Differences between Caucasian, African American, and Hispanic patients with primary biliary cirrhosis in the United States , 2007, Hepatology.
[15] Sarah M. Greene,et al. Building a virtual cancer research organization. , 2005, Journal of the National Cancer Institute. Monographs.
[16] B. McMahon,et al. Prevalence of autoimmune liver disease in Alaska natives , 2002, American Journal of Gastroenterology.
[17] E. Gold,et al. Risk factors for primary biliary cirrhosis in a cohort of patients from the United States , 2001, Hepatology.
[18] T. Therneau,et al. Epidemiology and natural history of primary biliary cirrhosis in a US community. , 2000, Gastroenterology.
[19] G. Minuk,et al. Clinical hepatology: Profile of an urban, hospital‐based practic , 1996, Hepatology.
[20] P. Angus,et al. Low prevalence of primary biliary cirrhosis in Victoria, Australia. Melbourne Liver Group. , 1995, Gut.
[21] Wei-Yin Loh,et al. Classification and regression trees , 2011, WIREs Data Mining Knowl. Discov..
[22] K. Lazaridis,et al. Primary biliary cirrhosis , 1998, Springer Netherlands.